Skip to main content
Caplight Logo









Voinosis

Voinosis

Private
SeoulHealthcare & Life Scienceshttps://voinosis.com/

Last Round

Strategic

Jul 7, 2026

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Voinosis is a healthcare technology company that develops AI-powered voice analysis solutions for the early detection and management of cognitive impairment, dementia, and hearing loss.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, NLP & Conversational AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

voice biomarkerdigital healthcognitive impairment detectiondementia screeningai diagnosticsdigital therapeuticsvoice analysisDTxmedical aispeech biomarkerclinical decision supportremote patient monitoringRPMvocal biomarkerhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Voinosis Comparables

Compare Voinosis with similar companies based on industry and business-model similarity.

Voinosis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AIBLE Therapeutics
89%
HAII
81%
Accexible
81%

Voinosis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 7, 2026
Early FundingJun 4, 2026
GrantMar 1, 2026

Key People

Founding team and executive leadership

Grace Jung Eun Shin

Chief Executive Officer Voinosis.inc

Executive Team

Voinosis Investors

Notable investors and investment history

Voinosis investors
InvestorRounds
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 7, 2026

    Daewoong Pharmaceutical participated in the round.

  • Jun 4, 2026

    Raised $4M in early funding.

Voinosis Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Voinosis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Voinosis's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range6
Year Founded2019
Last FundingJul 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?